Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis

References

• Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004; 100: 2026–46
   PubMed Web of Science ®Google Scholar
• Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury. Cancer 2004; 100: 1995–2025
   PubMed Web of Science ®Google Scholar
• Keefe DM, Schubert MM, Elting ST, Sonis ST, Epsteine JB, Raber-Durlacher JE, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007; 109: 820–31
   PubMed Web of Science ®Google Scholar
• Sartori S, Trevisani L, Nielsen I, Tassinari D., Abbasciano V. Misoprostol and omeprazole in the prevention of chemotherapy-induced acute gastroduodenal mucosal injury. A randomized, placebo-controlled pilot study. Cancer 1996; 78: 1477–82
   PubMed Web of Science ®Google Scholar
• Sartori S, Trevisani L, Nielsen I, Tassinari D, Panzini I, Abbasciano V. Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury. J Clin Oncol 2000; 18: 463–7
   PubMed Web of Science ®Google Scholar
• Brunner G, Hell M, Hengels KJ, Hennig U, Fuchs W. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers. Digestion 1995; 56: 137–44
   PubMed Web of Science ®Google Scholar
• Shimatani T, Inoue M, Kuroiwa T, Horikawa Y, Mieno H, Nakamura M. Effect of omeprazole 10 mg on intragastric pH in three different CYP2C19 genotypes, compared with omeprazole 20 mg and lafutidine 20 mg, a new H2-receptor antagonist. Aliment Pharmacol Ther 2003; 18: 1149–57
   PubMed Web of Science ®Google Scholar
• Azuumi Y, Ohara S, Ishihara K, Okabe H, Hotta K. Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats. Gut 1980; 21: 533–6
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Ishihara K, Komuro Y, Kojima Y, Saigenji K, Hotta K. Effects of the new histamine H2-receptor antagonist, FRG-8813, on gastric mucin in rats with or without acidified ethanol-induced gastric damage. Life Sci 1994; 54: PL159–64
   PubMed Web of Science ®Google Scholar
• Kojima Y, Ishihara K, Ohara S, Saigenji K, Hotta K. Effects of the M1 muscarinic receptor antagonist pirenzepine on gastric mucus glycoprotein in rats with or without ethanol-induced gastric damage. Scand J Gastroenterol 1992; 27: 764–8
   PubMed Web of Science ®Google Scholar
• Saegusa Y, Ichikawa T, Iwai T, Goso Y, Okayasu I, Ikezawa T, , et al. Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis. Scand J Gastroenterol 2007. In press.
   Google Scholar
• Ishihara K, Kurihara M, Goso Y, Ota H, Katsuyama T, Hotta K. Establishment of monoclonal antibodies against carbohydrate moiety of gastric mucins distributed in the different sites and layers of rat gastric mucosa. Glycoconj J 1996; 13: 857–64
   PubMed Web of Science ®Google Scholar
• Tsubokawa D, Goso Y, Sawaguchi A, Kurihara M, Ichikawa T, Sato N, et al. A monoclonal antibody, PGM34, against 6-sulfated blood-group H type 2 antigen, on the carbohydrate moiety of mucin. FEBS J 2007; 274: 1833–48
   PubMed Web of Science ®Google Scholar
• Ota H, Katsuyama T. Alternating laminated array of two types of mucin in the human gastric surface mucous layer. Histochem J 1992; 24: 86–92
   PubMedGoogle Scholar
• Blandizzi C, Natale G, Gherardi G, Lazzeri G, Marveggio C, Colucci R, et al. Acid-independent gastroprotective effects of lansoprazole in experimental mucosal injury. Dig Dis Sci 1999; 44: 2039–50
   PubMed Web of Science ®Google Scholar
• Onodera S, Shibata M, Tanaka M, Inaba N, Yamaura T, Ohnishi H. Gastroprotective activity of FRG-8813, a novel histamine H2-receptor antagonist, in rats. Jpn J Pharmacol 1995; 68: 161–73
   PubMedGoogle Scholar
• Shibata M, Yamaura T, Inaba N, Onodera S, Chiba Y, Ohnishi H. Gastric antisecretory effect of FRG-8813, a new histamine H2-receptor antagonist, in rats and dogs. Eur J Pharmacol 1993; 235: 245–53
   PubMed Web of Science ®Google Scholar
• Takeuchi K, Konaka A, Nishijima M, Kato S, Yasuhiro T. Effects of pantoprazole, a novel H + /K + -ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole. J Gastroenterol Hepatol 1999; 14: 251–7
   PubMed Web of Science ®Google Scholar
• Mori K, Tominaga K, Yokoyama K, Suga Y, Kishiro I, Tsurui M. Efficacy of famotidine in patients with acute gastric mucosal injury after continuous infusion of cisplatin plus vindesine. J Cancer Res Clin Oncol 1995; 121: 367–70
   PubMed Web of Science ®Google Scholar
• Kawakubo M, Ito Y, Okimura Y, Kobayashi M, Sakura K, Kasama S, et al. Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection. Science 2004; 305: 1003–6
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Ota H, Sugiyama A, Maruta F, Ikezawa T, Hotta K, , et al Effects of a novel histamine H2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa. J Gastroenterol Hepatol 2007. In press.
   Google Scholar
• Specian RD, Oliver MG. Functional biology of intestinal goblet cells. Am J Physiol 1991; 260: 183–93
   PubMed Web of Science ®Google Scholar
• Kato S, Tanaka A, Kunikata T, Umeda M, Takeuchi K. Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons. Digestion 2000; 61: 39–46
   PubMed Web of Science ®Google Scholar
• Tanaka A, Mizoguchi H, Hase S, Miyazawa T, Takeuchi K. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats: role of endogenous nitric oxide. Med Sci Monit 2001; 7: 869–77
   PubMedGoogle Scholar
• Mitchell EP. Gastrointestinal toxicity of chemotherapeutic agents. Semin Oncol 1992; 19: 566–79
   PubMed Web of Science ®Google Scholar
• Dilloway MR, Lant AF. Effect of H2-receptor antagonists on the pharmacokinetics of 5-fluorouracil in the rat and monkey. Biopharm Drug Dispos 1991; 12: 17–28
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Ishihara K, Saigenji K, Hotta K. Effects of acid-inhibitory antiulcer drugs on mucin biosynthesis in the rat stomach. Eur J Pharmacol 1994; 251: 107–11
   PubMed Web of Science ®Google Scholar
• Ichikawa T, Ishihara K, Shibata M, Yamaura T, Saigenji K, Hotta K. Stimulation of mucin biosynthesis in rat gastric mucosa by FRG-8813 and its structural analogs. Eur J Pharmacol 1996; 297: 87–92
   PubMed Web of Science ®Google Scholar
• Ichikawa H, Yoshida N, Takagi T, Tomatsuri N, Katada K, Isozaki Y, et al. Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. World J Gastroenterol 2004; 10: 2814–7
   PubMed Web of Science ®Google Scholar
• Kuroda M, Yoshida N, Ichikawa H, Takagi T, Okuda T, Naito Y, et al. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int J Mol Med 2006; 17: 89–93
   PubMed Web of Science ®Google Scholar
• Pozzoli C, Mezozii A, Grandi D, Solenghi E, Ossiprandi MC, Zullian C, et al. Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine. Naunyn Schmiedebergs Arch Pharmacol 2007; 374: 283–91
   PubMed Web of Science ®Google Scholar